| Literature DB >> 31506746 |
Thomas M Lilley1,2, Jenni M Prokkola3, Anna S Blomberg4, Steve Paterson3, Joseph S Johnson5, Gregory G Turner6, Tomáš Bartonička7, Erik Bachorec7, DeeAnn M Reeder8, Kenneth A Field8.
Abstract
Resistance and tolerance allow organisms to cope with potentially life-threatening pathogens. Recently introduced pathogens initially induce resistance responses, but natural selection favors the development of tolerance, allowing for a commensal relationship to evolve. Mycosis by Pseudogymnoascus destructans, causing white-nose syndrome (WNS) in Nearctic hibernating bats, has resulted in population declines since 2006. The pathogen, which spread from Europe, has infected species of Palearctic Myotis for a longer period. We compared ecologically relevant responses to the fungal infection in the susceptible Nearctic M. lucifugus and less susceptible Palearctic M. myotis, to uncover factors contributing to survival differences in the two species. Samples were collected from euthermic bats during arousal from hibernation, a naturally occurring phenomenon, during which transcriptional responses are activated. We compared the whole-transcriptome responses in wild bats infected with P. destructans hibernating in their natural habitat. Our results show dramatically different local transcriptional responses to the pathogen between uninfected and infected samples from the two species. Whereas we found 1526 significantly upregulated or downregulated transcripts in infected M. lucifugus, only one transcript was downregulated in M. myotis. The upregulated response pathways in M. lucifugus include immune cell activation and migration, and inflammatory pathways, indicative of an unsuccessful attempt to resist the infection. In contrast, M. myotis appears to tolerate P. destructans infection by not activating a transcriptional response. These host-microbe interactions determine pathology, contributing to WNS susceptibility, or commensalism, promoting tolerance to fungal colonization during hibernation that favors survival.Entities:
Keywords: Host–pathogen interaction; Infection; Opportunistic pathogen; Resistance; Tolerance
Mesh:
Substances:
Year: 2019 PMID: 31506746 PMCID: PMC6763535 DOI: 10.1007/s00442-019-04499-6
Source DB: PubMed Journal: Oecologia ISSN: 0029-8549 Impact factor: 3.225
Fig. 1a Loads of P. destructans in each sample determined by read mapping, b Principal component analysis of host transcript expression after removal of P. destructans reads. The load of P. destructans in each biopsy was determined by estimating P. destructans transcript counts in transcripts per million mapped reads (TPM). The multidimensional scaling plot shows pairwise comparisons of M. lucifugus transcript expression using moderated log CPM expression levels. Samples are colored by group, as indicated on the legend. Dimension 1 represents 49% of the variance dimension 2 represents 25% of the variance
Fig. 2Differential expression of transcripts in tissues infected with P. destructans in aM. lucifugus, b in M. myotis and c a comparison of expression in both host species. The mean expression level (log2 counts per million (CPM)) and the fold change (log2 FC) are shown for each transcript. Red points indicate differential expression (FDR ≤ 0.05 determined by edgeR). An interactive version of a is available at https://digitalcommons.bucknell.edu/fac_pubs/133/ and b at https://digitalcommons.bucknell.edu/fac_pubs/134/. The Venn diagram indicates the overlapping subsets of significantly differentially expressed transcripts (FDR < 0.05) in M. lucifugus (Mylu) and M. myotis (Mymy) samples
Select immune genes differentially expressed in UV-positive tissue with P. destructans in M. myotis and M. lucifugus
| Transcript | Name | Description |
|
| ||
|---|---|---|---|---|---|---|
| FC | FDR | FC | FDR | |||
| ENSMLUT00000015856 | IL6 | Interleukin 6 | 9.58 | 9.65e-26 | NA | NA |
| ENSMLUT00000011363 | CCL2 | C–C motif chemokine 2 | 7.46 | 5.92e-25 | 1.67 | 1 |
| ENSMLUT00000008206 | PTGS2 | Prostaglandin-endoperoxide synthase 2 | 15.89 | 1.87e-20 | 1.27 | 1 |
| ENSMLUT00000008807 | HMOX1 | Heme oxygenase 1 | 4.20 | 9.96e-17 | 1.21 | 1 |
| ENSMLUT00000012289 | ICAM1 | Intercellular adhesion molecule 1 | 4.29 | 3.11e-16 | 1.57 | 1 |
| ENSMLUT00000016420 | THBS1 | Thrombospondin 1 | 6.28 | 1.72e-13 | 1.06 | 1 |
| ENSMLUT00000001355 | MMP25 | Matrix metallopeptidase 25 | 35.75 | 2.39e-13 | 2.19 | 1 |
| ENSMLUT00000004880 | CXCR2 | C-X-C motif chemokine receptor 2 | 24.25 | 2.53e-13 | 2.60 | 1 |
| ENSMLUT00000015164 | NOD2 | Nucleotide binding oligomerization domain containing 2 | 3.86 | 3.41e-13 | 1.20 | 1 |
| ENSMLUT00000029244 | TNFAIP6 | TNF alpha induced protein 6 | 3.81 | 6.61e-13 | 1.18 | 1 |
| ENSMLUT00000011581 | CLEC4E | C-type lectin domain family 4 member E | 29.04 | 7.63e-12 | NA | NA |
| ENSMLUT00000000289 | MMP9 | Matrix metallopeptidase 9 | 12.21 | 1.38e-10 | 3.18 | 0.09 |
| ENSMLUT00000002542 | CXCL16 | C-X-C motif chemokine ligand 16 | 2.35 | 1.49e-09 | 1.25 | 1 |
| ENSMLUT00000000473 | ANXA1 | Annexin A1 | 2.87 | 1.55e-09 | 0.96 | 1 |
| ENSMLUT00000008598 | SELE | Selectin E | 4.86 | 2.21e-09 | 0.93 | 1 |
| ENSMLUT00000014922 | SHB | SH2 domain containing adaptor protein B | 2.06 | 7.73e-09 | 1.13 | 1 |
| ENSMLUT00000012386 | FFAR2 | Free fatty acid receptor 2 | 14.72 | 9.26e-09 | 4.76 | 0.22 |
| ENSMLUT00000003161 | ITGB2 | Integrin subunit beta 2 | 17.88 | 9.69e-09 | 2.71 | 0.54 |
| ENSMLUT00000011719 | NR4A3 | Nuclear receptor subfamily 4 group A member 3 | 2.77 | 1.59e-08 | 1.00 | 1 |
| ENSMLUT00000006594 | RELB | RELB proto-oncogene, NF-kB subunit | 2.14 | 1.73e-08 | 1.18 | 1 |
| ENSMLUT00000002906 | S100A8 | S100 calcium binding protein A8 | 3.76 | 4.98e-08 | 1.29 | 1 |
| ENSMLUT00000003286 | SBNO2 | Strawberry notch homolog 2 | 2.64 | 1.02e-07 | 1.15 | 1 |
| ENSMLUT00000011146 | TRPM2 | Transient receptor potential cation channel subfamily M member 2 | 14.62 | 1.29e-07 | NA | NA |
| ENSMLUT00000012815 | TLR2 | Toll like receptor 2 | 3.29 | 1.33e-07 | 1.13 | 1 |
| ENSMLUT00000003912 | TLR7 | Toll like receptor 7 | 6.87 | 1.71e-07 | NA | NA |
| ENSMLUT00000007434 | PTPN22 | Protein tyrosine phosphatase, non-receptor type 22 | 10.56 | 1.71e-07 | 1.41 | 1 |
| ENSMLUT00000014401 | LCP1 | Lymphocyte cytosolic protein 1 | 19.03 | 2.19e-07 | 3.03 | 0.43 |
| ENSMLUT00000008567 | SELL | Selectin L | 42.81 | 2.31e-07 | 3.34 | 1 |
| ENSMLUT00000012752 | TLR8 | Toll like receptor 8 | 29.04 | 3.63e-07 | NA | NA |
| ENSMLUT00000003440 | CORO1A | Coronin 1A | 6.77 | 4.03e-07 | 1.68 | 1 |
| ENSMLUT00000008354 | ITGAL | Integrin subunit alpha L | 14.42 | 1.03e-06 | NA | NA |
| ENSMLUT00000031197 | S100A9 | S100 calcium binding protein A9 | 4.38 | 2.01e-06 | 1.25 | 1 |
| ENSMLUT00000000160 | PTAFR | Platelet activating factor receptor | 6.96 | 2.05e-06 | 2.01 | 1 |
| ENSMLUT00000022221 | JAML | Junction adhesion molecule like | 4.06 | 2.22e-06 | 1.16 | 1 |
| ENSMLUT00000001008 | SERPINE1 | Serpin family E member 1 | 3.53 | 2.72e-06 | 1.32 | 1 |
| ENSMLUT00000015767 | THY1 | Thy-1 cell surface antigen | 3.36 | 6.87e-06 | 1.03 | 1 |
| ENSMLUT00000000245 | TFRC | Transferrin receptor | 2.46 | 1.01e-05 | 0.92 | 1 |
| ENSMLUT00000014583 | FGR | FGR protooncogene Src tyrosine kinase | 8.57 | 1.66e-05 | 1.91 | 1 |
| ENSMLUT00000007409 | TLR4 | Toll like receptor 4 | 3.84 | 2.07e-05 | 1.32 | 1 |
| ENSMLUT00000008843 | IL17C | Interleukin 17C | 5.39 | 2.10e-05 | NA | NA |
Ensembl transcript ID and gene name are listed for selected transcripts differentially expressed in M. lucifugus between UV-negative and UV-positive tissue. The fold change (FC) and Benjamini–Hochberg adjusted p value (FDR) calculated by edgeR are shown for each transcript for samples from both M. lucifugus and M. myotis samples. Bold FDR values indicate ≤ 0.05. NA indicates transcripts that were removed by filtering for low expression level (TPM < 1 in 5 or more samples) prior to edgeR testing. See Table S1 for results for all transcripts
Fig. 3Chordplot of genes involved in immune responses in M. lucifugus identified by gene ontology analysis. Connections from the right side of the figure to the left signify associations between transcripts and selected biological process categories. All transcripts differentially expressed (FDR < 0.05 by edgeR) are shown that were annotated in the following categories: GO: 0,002,366 (leucocyte activation involved in immune response (orange)), GO: 0,050,900 (Leukocyte migration (blue)), and GO: 0,006,954 (Inflammatory response (green)). Expression level changes (log2 fold change) are shown for the comparison of UV-negative to UV-positive M. lucifugus (outer heatmap) and UV-negative to UV-positive M. myotis (inner heatmap) (color figure online)
Fig. 4Normalized expression levels of transcripts among M. lucifugus (Wisconsin and Pennsylvania, left to right) and M. myotis involved in a leukocyte activation, b leukocyte migration and c inflammatory response. All transcripts differentially expressed in Pennsylvania M. lucifugus samples (FDR < 0.05 by edgeR) are shown that were annotated in the following categories: a GO:0,002,366 (leucocyte activation involved in immune response (orange)), b GO: 0,050,900 (Leukocyte migration (blue)), and c GO: 0,006,954 (Inflammatory response (green)) (color figure online)